Hengrui Medicine Chairman: Extend New Drug Patent Protection
This article was originally published in PharmAsia News
Executive Summary
Hengrui Medicine Chairman Sun Piao-Yang recently commented on the need for the Chinese biopharmaceutical industry to strengthen innovation and international competitiveness